基本信息
浏览量:23
职业迁徙
个人简介
Prof O’Byrne’s major contribution has been the development of multi-disciplinary research teams and organisations. He supervises one team in Brisbane working with Assoc Prof Derek Richard on DNA stability and another in Dublin, on cell signalling mechanisms involved in resistance to cisplatin chemotherapy and targeted agents, and has set up the British Thoracic Oncology Group (BTOG) and am the lifelong President, and a co-founder of the European Thoracic Oncology Platform (ETOP). He also works on the fellowship and CME committees of the IASLC.
His current research interests include exploring the potential role of DNA stability in regulation of the androgen receptor and as a target for therapy for prostate cancer patients. He also plays a lead role in the clinical trials unit on the PAH campus, investigating treatments such as OGX-011, a clusterin antisense therapy, in patient volunteers with prostate cancer.
Prof O’Byrne is an expert in translational and clinical research, specialising in cancer incorporating basic science, biomarkers, therapeutic target evaluation and phase I, II and III clinical trials collaborating with both academic and industrial partners. He has been a PI, co-PI, CI or collaborator on grants worth in excess of $50M over the past 5 years including the award of a 5 year Senior Clinical Research Fellowship by the Queensland Government, through the Office of Health and Medical Research in 2012 totalling $4.25M to support the establishment of a Translational Cancer Research Group at the Princess Alexandra Hospital and Translational Research Institute. In 2013 alone he has been co-author on a number of high impact papers in the New England Journal of Medicine (PMID: 23724913), Journal of Clinical Oncology (PMID: 23816967; PMID: 23816960) and Journal of the National Cancer Institute (PMID: 23468463).
His current research interests include exploring the potential role of DNA stability in regulation of the androgen receptor and as a target for therapy for prostate cancer patients. He also plays a lead role in the clinical trials unit on the PAH campus, investigating treatments such as OGX-011, a clusterin antisense therapy, in patient volunteers with prostate cancer.
Prof O’Byrne is an expert in translational and clinical research, specialising in cancer incorporating basic science, biomarkers, therapeutic target evaluation and phase I, II and III clinical trials collaborating with both academic and industrial partners. He has been a PI, co-PI, CI or collaborator on grants worth in excess of $50M over the past 5 years including the award of a 5 year Senior Clinical Research Fellowship by the Queensland Government, through the Office of Health and Medical Research in 2012 totalling $4.25M to support the establishment of a Translational Cancer Research Group at the Princess Alexandra Hospital and Translational Research Institute. In 2013 alone he has been co-author on a number of high impact papers in the New England Journal of Medicine (PMID: 23724913), Journal of Clinical Oncology (PMID: 23816967; PMID: 23816960) and Journal of the National Cancer Institute (PMID: 23468463).
研究兴趣
论文共 838 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
M. J. Hochmair, K. Vermaelen, G. Mountzios, E. Carcereny, C. Dooms,S. -h. Lee, E. M. Morocz, T. Kato, T-e. Ciuleanu,G. Dy, M. B. M. C. S. Parente,K. J. O'Byrne,
A. P. Wiegmans, E. Ivanova, V. Y. Naei, J. Monkman, J. Fletcher, W. Mullally, M. E. Warkiani,K. O’Byrne,A. Kulasinghe
Niyati Jhaveri,Bassem Ben Cheikh, Nadezhda Nikulina,Ning Ma,Dmytro Klymyshyn, James DeRosa, Ritu Mihani,Aditya Pratapa,Yasmin Kassim, Sidharth Bommakanti,Olive Shang, Shannon Berry,
GEN BIOTECHNOLOGYno. 5 (2023): 418-434
IMMUNOLOGYno. 4 (2023): 487-502
Zachariah P. Schuurs, Alexander P. Martyn, Carl P. Soltau,Sam Beard,Esha T. Shah,Mark N. Adams,Laura V. Croft,Kenneth J. O'Byrne,Derek J. Richard,Neha S. Gandhi
BIOLOGY-BASELno. 11 (2023): 1405-1405
Journal of Thoracic Oncologyno. 11 (2023): S256-S256
M. Itchins, S. Liang, C. Brown, T. Barnes, G. Marx, V. Chin, S. Kao, P. Y. Yip, A. J. Mersiades, A. Nagrial, V. Bray, G. Peters,
JOURNAL OF THORACIC ONCOLOGYno. 11 (2023): S351-S352
引用0浏览0引用
0
0
K. O'Byrne, E. Popoff, F. Badin,A. Lee, Y. Yuan, S. Goring, L. J. Eccles, N. Varol, N. Waser,J. R. Penrod, G. Lozano-Ortega
JOURNAL OF THORACIC ONCOLOGYno. 11 (2023): S629-S630
引用0浏览0引用
0
0
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn